Nec Med Pharma GmbH

Nec Med Pharma GmbH is a pharmaceutical company based in Germany, specializing in intelligent procurement and sales solutions tailored for the pharmaceutical industry. Nec Med Pharma GmbH focuses on providing procurement and sales solutions specifically designed for the pharmaceutical sector. Founded in Germany, the company has undergone significant developments in its operational strategy. The current CEO, Hendrik Schramm, leads the firm, which has engaged in at least one notable funding deal.

In December 2016, NORD Holding acquired a majority stake in Nec Med Pharma, with the deal details undisclosed. The company is headquartered in Germany. Nec Med Pharma specializes in providing intelligent procurement and sales solutions tailored for the pharmaceutical industry. The company leverages a robust network of experienced contacts to facilitate the distribution of various pharmaceutical products, including medications and dietary supplements.

Their core services encompass market analysis, negotiation of pricing structures, and strategic marketing implementations that ensure optimal product placement and accessibility. Nec Med Pharma's client base includes pharmaceutical manufacturers, wholesalers, and retailers across diverse geographical markets, including Germany and potentially other regions in Europe. The company’s commitment to enhancing market knowledge and establishing effective distribution policies aids clients in navigating the complex landscape of pharmaceutical sales, ultimately driving product success in competitive environments. Nec Med Pharma generated revenue of EUR 97.

35 mn in 2022, with an EBITDA of EUR 1. 85 mn. The company primarily engages in B2B transactions with pharmaceutical companies, wholesalers, and retailers to create effective supply chain solutions that meet specific market demands. The transaction structure involves partnerships and consultancy agreements that allow clients to access a range of services, from market entry strategies to tailored distribution channels.

The firm actively negotiates favorable purchasing terms for clients, aligning successful sales and procurement with market needs. Looking ahead, Nec Med Pharma GmbH plans to expand its service offerings and explore new markets beyond Germany, with strategic initiatives focusing on the broader European market. The company intends to utilize its recent funding to support the development of new products and enhance its existing procurement solutions. Their approach will include launching innovative sales methodologies to better serve clients in a rapidly evolving market.

The completion of the acquisition by NORD Holding in December 2016 is expected to bolster these growth strategies and provide additional resources for expansion.